Lupin gets US FDA approval for generic version of Doxycyclin

Doxycycline Hyclate Delayed-Release Tablets USP had estimated annual sales of $9 million in the US.

Related Keywords

India , United States , , Drug Administration , Lupin Digital Health , United States Food , Doxycycline Hyclate Delayed Release , Doxycycline Hyclate Delayed Release Tablets , Doryx Delayed Release Tablets , Release Tablets , Us Fda , Lupin , Generic Drug ,